SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-310331
Filing Date
2014-08-14
Accepted
2014-08-14 17:02:16
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d760875d10q.htm 10-Q 363968
2 EX-31.1 d760875dex311.htm EX-31.1 8060
3 EX-31.2 d760875dex312.htm EX-31.2 8037
4 EX-32.1 d760875dex321.htm EX-32.1 3039
  Complete submission text file 0001193125-14-310331.txt   3062345

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xbio-20140630.xml EX-101.INS 330603
6 XBRL TAXONOMY EXTENSION SCHEMA xbio-20140630.xsd EX-101.SCH 37635
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbio-20140630_cal.xml EX-101.CAL 55347
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbio-20140630_def.xml EX-101.DEF 99670
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbio-20140630_lab.xml EX-101.LAB 274676
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbio-20140630_pre.xml EX-101.PRE 192067
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7722
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-178082 | Film No.: 141044022
SIC: 2834 Pharmaceutical Preparations